The requirement for cyclin D function in tumor maintenance.

The requirement for cyclin D function in tumor maintenance.
复制标题

DOI:
10.1016/j.ccr.2012.09.015
复制
发表时间:
2012-10-16
期刊:
影响因子:
50.3
通讯作者:
Sicinski P
Sicinski P
中科院分区:
医学1区
文献类型:
--
作者:
Choi YJ;Li X;Hydbring P;Sanda T;Stefano J;Christie AL;Signoretti S;Look AT;Kung AL;von Boehmer H;Sicinski P

文献摘要

参考文献

被引文献

相似文献

D-细胞周期蛋白代表细胞周期机制的组成部分。为了测试靶向D-细胞周期蛋白在癌症治疗中的功效,我们设计了小鼠品系,其允许在活体动物中急性和整体消融个体D-细胞周期蛋白。在携带ErbB 2驱动的乳腺癌的小鼠中,细胞周期蛋白D1的普遍关闭或细胞周期蛋白D相关激酶活性的抑制引发了肿瘤细胞衰老,而不损害动物的健康。在携带Notch 1驱动的T细胞急性淋巴细胞白血病(T-ALL)的小鼠中,细胞周期蛋白D3的消融引发了肿瘤细胞凋亡。这种选择性杀伤白血病细胞也可以通过抑制小鼠和人T-ALL模型中的细胞周期蛋白D相关激酶活性来实现。细胞周期蛋白D激酶活性的抑制代表了一种高选择性的抗癌策略,其特异性靶向癌细胞而不显著影响正常组织。
D-cyclins represent components of cell cycle machinery. To test the efficacy of targeting D-cyclins in cancer treatment, we engineered mouse strains which allow acute and global ablation of individual D-cyclins in a living animal. Ubiquitous shutdown of cyclin D1 or inhibition of cyclin D-associated kinase activity in mice bearing ErbB2-driven mammary carcinomas triggered tumor cell senescence, without compromising the animals’ health. Ablation of cyclin D3 in mice bearing Notch1-driven T-cell acute lymphoblastic leukemias (T-ALL) triggered tumor cell apoptosis. Such selective killing of leukemic cells can also be achieved by inhibiting cyclin D-associated kinase activity in mouse and human T-ALL models. Inhibition of cyclin D-kinase activity represents a highly-selective anti-cancer strategy that specifically targets cancer cells without significantly affecting normal tissues.
DOI: 10.1038/nature07319
发表时间: 2008-10-30
期刊: NATURE
影响因子: 64.8
作者:
Lin, Yingxi;Bloodgood, Brenda L.;Hauser, Jessica L.;Lapan, Ariya D.;Koon, Alex C.;Kim, Tae-Kyung;Hu, Linda S.;Malik, Athar N.;Greenberg, Michael E.
通讯作者: Greenberg, Michael E.
DOI: 10.1038/nature08822
发表时间: 2010-02-18
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1084/jem.20081561
发表时间: 2008-11-24
影响因子: 15.3
作者:
Li, Xiaoyu;Gounari, Fotini;Protopopov, Alexei;Khazaie, Khashayarsha;von Boehmer, Harald
通讯作者: von Boehmer, Harald
DOI: 10.1016/j.ccr.2011.10.001
发表时间: 2011-11-15
期刊: Cancer cell
影响因子: 50.3
作者:
Anders L;Ke N;Hydbring P;Choi YJ;Widlund HR;Chick JM;Zhai H;Vidal M;Gygi SP;Braun P;Sicinski P
通讯作者: Sicinski P
DOI: 10.1038/onc.2010.154
发表时间: 2010-07-15
期刊: ONCOGENE
影响因子: 8
作者:
Dean, J. L.;Thangavel, C.;Knudsen, E. S.
通讯作者: Knudsen, E. S.